Page last updated: 2024-08-23

paclitaxel and Nasal Septal Perforation

paclitaxel has been researched along with Nasal Septal Perforation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aoki, Y; Arakaki, Y; Kudaka, W; Nakamoto, T; Nakasone, T; Shimoji, Y; Taira, Y1
Cruz, JJ; Gomez, A; Lozano, R; Martin, T; Rodriguez, CA1

Other Studies

2 other study(ies) available for paclitaxel and Nasal Septal Perforation

ArticleYear
A case of nasal septal perforation caused by bevacizumab for advanced cervical cancer.
    The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:2

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Female; Humans; Middle Aged; Nasal Septal Perforation; Paclitaxel; Uterine Cervical Neoplasms

2021
Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
    The breast journal, 2017, Volume: 23, Issue:6

    Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Nasal Septal Perforation; Neoplasm Metastasis; Paclitaxel

2017